Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models-Reference-Cited by-同舟云学术

Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models

Published:2015-05-15 Issue:7 Volume:7 Page:895-903
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Maia Luis F¹²³,Kaeser Stephan A¹²,Reichwald Julia⁴,Lambert Marius¹²,Obermüller Ulrike¹²,Schelle Juliane¹²,Odenthal Jörg¹²,Martus Peter⁵,Staufenbiel Matthias¹²⁴,Jucker Mathias¹²

Affiliation:

1. Department of Cellular Neurology Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany

2. DZNE German Center for Neurodegenerative Diseases Tübingen Germany

3. Department of Neurology Hospital de Santo António‐CHP Porto Portugal

4. Novartis Institutes for Biomedical Research Neuroscience Discovery Basel Basel Switzerland

5. Institute of Clinical Epidemiology and applied Biostatistics University of Tübingen Tübingen Germany

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201505026

Reference34 articles.

1. Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition

2. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

3. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

4. Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid

5. Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher Cerebrospinal Fluid Levels of Amyloid-β40 Following Traumatic Brain Injury Relate to Confrontation Naming Performance;Journal of Alzheimer's Disease;2024-07-16

2. Association of cigarette smoking with cerebrospinal fluid biomarkers of insulin sensitivity and neurodegeneration;Brain and Behavior;2024-02

3. Clinical efficacy and controversies of aducanumab;International Conference on Modern Medicine and Global Health (ICMMGH 2023);2023-09-07

4. Amyloid-β slows cilia movement along the ventricle, impairs fluid flow, and exacerbates its neurotoxicity in explant culture;Scientific Reports;2023-08-21

5. Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the AppNL−F/NL−F knock-in mouse model of Alzheimer’s disease;Alzheimer's Research & Therapy;2023-03-25